This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175–1183.
Majhail NS . Secondary cancers following allogeneic haematopoietic cell transplantation in adults. Br J Haematol 2011; 154: 301–310.
Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904.
Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789.
Au WY, Pang A, Chan EC, Chu KM, Shek TW, Kwong YL . Epstein-barr virus-related gastric adenocarcinoma: an early secondary cancer post hemopoietic stem cell transplantation. Gastroenterology 2005; 129: 2058–2063.
Gallagher G, Forrest DL . Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer 2007; 109: 84–92.
Au WY, Chan EC, Pang A, Lie AK, Liang R, Yuen AP et al. Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring. Bone Marrow Transplant 2004; 34: 981–985.
Hu YX, Cui Q, Liang B, Huang H . Donor-derived solid malignancies after hematopoietic stem cell transplantation. Onkologie 2010; 33: 195–200.
Schreiber RD, Old LJ, Smyth MJ . Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331: 1565–1570.
Smyth MJ, Dunn GP, Schreiber RD . Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90: 1–50.
Acknowledgements
We would like to acknowledge Drs Mark Raffeld and Svetlana Pack (Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892) for their help with TCR rearrangement and fluorescent in situ hybridization studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Davidson-Moncada, J., Pittaluga, S., Roth, M. et al. Second cancers early post allogeneic transplant: the case of ‘unrestrained’ malignancy?. Bone Marrow Transplant 48, 872–874 (2013). https://doi.org/10.1038/bmt.2012.238
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.238